Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP337767.RAlY-hTK-D5c9G9a2Gxc3zfoJ665oiFdv6FU4Rkraclxo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP337767.RAlY-hTK-D5c9G9a2Gxc3zfoJ665oiFdv6FU4Rkraclxo130_assertion type Assertion NP337767.RAlY-hTK-D5c9G9a2Gxc3zfoJ665oiFdv6FU4Rkraclxo130_head.
- NP337767.RAlY-hTK-D5c9G9a2Gxc3zfoJ665oiFdv6FU4Rkraclxo130_assertion description "[Administration of cDNA encoding soluble IFN-gamma receptor (IFN-gamma R)/IgG-Fc fusion proteins, soluble TNF-alpha receptors, or IL-1 receptor antagonist (IL-1ra), protects against either lupus, various forms of arthritis, autoimmune diabetes, or other autoimmune diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP337767.RAlY-hTK-D5c9G9a2Gxc3zfoJ665oiFdv6FU4Rkraclxo130_provenance.
- NP337767.RAlY-hTK-D5c9G9a2Gxc3zfoJ665oiFdv6FU4Rkraclxo130_assertion evidence source_evidence_literature NP337767.RAlY-hTK-D5c9G9a2Gxc3zfoJ665oiFdv6FU4Rkraclxo130_provenance.
- NP337767.RAlY-hTK-D5c9G9a2Gxc3zfoJ665oiFdv6FU4Rkraclxo130_assertion SIO_000772 11727511 NP337767.RAlY-hTK-D5c9G9a2Gxc3zfoJ665oiFdv6FU4Rkraclxo130_provenance.
- NP337767.RAlY-hTK-D5c9G9a2Gxc3zfoJ665oiFdv6FU4Rkraclxo130_assertion wasDerivedFrom befree-2016 NP337767.RAlY-hTK-D5c9G9a2Gxc3zfoJ665oiFdv6FU4Rkraclxo130_provenance.
- NP337767.RAlY-hTK-D5c9G9a2Gxc3zfoJ665oiFdv6FU4Rkraclxo130_assertion wasGeneratedBy ECO_0000203 NP337767.RAlY-hTK-D5c9G9a2Gxc3zfoJ665oiFdv6FU4Rkraclxo130_provenance.